SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Enzon Pharmaceuticals, Inc. to Sell Specialty Pharmaceuticals Business to the Sigma-Tau Group for $300 Million Plus up to $27 Million